Virbagest 4mg/ml Oral Suspension for Pigs
국가: 루마니아
언어: 영어
출처: HMA (Heads of Medicines Agencies)
제품 특성 요약
(SPC)
03-09-2013
이 제품에 대한 일부 문서는 현재 사용할 수 없습니다. 고객 서비스에 요청을 보내면 가능한 빨리 알려 드리겠습니다.
요청을 보내십시오.
요청을 보내십시오.
유효 성분:
altrenogest 4 mg
제공처:
Virbac S.A.
ATC 코드:
QG03DX90
약제 형태:
Oral solution
치료 그룹:
Altrenogest
치료 영역:
Pigs
승인 날짜:
2009-05-27
제품 특성 요약
Revised: December 2012
AN. 01534/2011
Page 1 of 5
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
VIRBAGEST 4 mg/ml oral solution for pigs
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
ACTIVE SUBSTANCE:
Altrenogest
4.00 mg/ml
EXCIPIENTS:
Butylhydroxytoluene (E321) 0.07 mg/ml
Butylhydroxyanisole (E320) 0.07 mg/ml
For a full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Oral solution for top-dressing use.
Clear, slightly yellow solution.
4.
CLINICAL PARTICULARS
4.1 TARGET SPECIES
Pigs (nulliparous mature sows).
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
For the synchronisation of oestrus in nulliparous mature sows.
4.3 CONTRAINDICATIONS
Do not use in boars.
Do not administer to pregnant sows (see section 4.7) or those suffering from uterine
infection.
Do not use in case of hypersensitivity to the active substance.
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
None.
4.5 SPECIAL PRECAUTIONS FOR USE
SPECIAL PRECAUTIONS FOR USE IN ANIMALS
Revised: December 2012
AN. 01534/2011
Page 2 of 5
Ensure the correct dose is administered daily as under dosing can lead to the formation
of cystic follicles.
Add the veterinary medicinal product to the feed immediately before feeding. Discard
any uneaten medicated feed.
Use only in sexually mature gilts that have been in oestrus.
Part consumed feed must be safely disposed of and not given to any other animal.
SPECIAL PRECAUTIONS TO BE TAKEN BY THE PERSON ADMINISTERING THE VETERINARY
MEDICINAL PRODUCT TO ANIMALS
Women who are pregnant, or
전체 문서 읽기
